Italy's Errani denies using banned substance

Image
IANS Madrid
Last Updated : Aug 08 2017 | 2:13 PM IST

Italy's Sara Errani, who was suspended by the International Tennis Federation (ITF) for two months after she failed a drug test, said she never took any banned substances.

"I never took, in my life and during my career, any prohibited substance," the 30-year-old Errani said in a statement posted in her Twitter account on Monday, reports Efe.

A urine sample that Errani provided on February 16 and was tested in Montreal contained letrozole, which is on the World Anti-Doping Agency's prohibited substances list, the ITF said in a statement.

"An Independent Tribunal ... has found that Sara Errani committed an Anti-Doping Rule Violation under Article 2.1 of the Programme and, as a consequence, has disqualified the affected results and imposed a period of ineligibility of two months, commencing on 3 August 2017," the ITF said.

Errani, for her part, said letrozole "is present in Femara, a medicine my mother has been using daily since 2012 for therapeutic purpose, further to a surgery for breast cancer, and therefore is present in the house where I am currently living."

The tennis player said she never took any letrozole and suspected that "accidental food contamination occurred at some stage in the house".

"I feel very frustrated. I had not done anything wrong," Errani said.

The ITF said Errani's results, points and prize money earned between February 16, when she provided the positive sample, and June 7, when she passed another drug test, would be disqualified.

Errani, the World No.98, made it to the semis at the Rabat International, her best singles result this season.

The Italian WTA Tour veteran reached her only Grand Slam final at the 2012 French Open.

--IANS

gau/vt

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 08 2017 | 2:02 PM IST

Next Story